Acute promyelocytic leukemia:: the study of t(15;17) translocation by fluorescent in situ hybridization, reverse transcriptase-polymerase chain reaction and cytogenetic techniques

被引:15
作者
Chauffaille, MLLF [1 ]
Figueiredo, MS [1 ]
Beltrani, R [1 ]
Antunes, SV [1 ]
Yamamoto, M [1 ]
Kerbauy, J [1 ]
机构
[1] Univ Fed Sao Paulo, EPM, Disciplina Hematol & Hemoterapia, BR-04023900 Sao Paulo, SP, Brazil
关键词
acute promyelocytic leukemia; karyotype; FISH; RT-PCR; PML/RARA gene rearrangement;
D O I
10.1590/S0100-879X2001000600006
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Acute promyelocytic leukemia (AML M3) is a well-defined subtype of leukemia with specific and peculiar characteristics. Immediate identification of t(15;17) or the PML/RARA gene rearrangement is fundamental for treatment. The objective of the present study was to compare fluorescent in situ hybridization (FISH), reverse transcriptase-polymerase chain reaction (RT-PCR) and karyotyping in 18 samples (12 at diagnosis and 6 after treatment) from 13 AML M3 patients. Bone marrow samples were submitted to karyotype G-banding, FISH and RT-PCR. At diagnosis, cytogenetics was successful in 10 of 12 samples, 8 with t(15;17) and 2 without. FISH was positive in 11/12 cases tone had no cells for analysis) and positivity varied from 25 to 93% (mean: 56%). RT-PCR was done in 6/12 cases and all were positive. Four of 8 patients with t(15;17) presented positive RT-PCR as well as 2 without metaphases. The lack of RT-PCR results in the other samples was due to poor quality RNA. When the three tests were compared at diagnosis, karyotyping presented the translocation in 80% of the tested samples while FISH and RT-PCR showed the PML/ RARA rearrangement in 100% of them. Of 6 samples evaluated after treatment, 3 showed a normal karyotype, 1 persistence of an abnormal clone and 2 no metaphases. FISH was negative in 4 samples studied and 2 had no material for analysis. RT-PCR was positive in 4 (2 of which showed negative FISH, indicating residual disease) and negative in 2. When the three tests were compared after treatment, they showed concordance in 2 of 6 samples or, when there were not enough cells for all tests, concordance between karyotype and RT-PCR in one. At remission, RT-PCR was the most sensitive test in detecting residual disease, as expected (positive in 3/6 samples). An incidence of about 40% of 5 ' breaks and 60% of 3 ' breaks, i.e., bcr3 and bcr1/bcr2, respectively, was observed.
引用
收藏
页码:735 / 743
页数:9
相关论文
共 27 条
[1]  
Allford S, 1999, BRIT J HAEMATOL, V105, P198
[2]   PROPOSALS FOR CLASSIFICATION OF ACUTE LEUKEMIAS [J].
BENNETT, JM ;
CATOVSKY, D ;
DANIEL, MT ;
FLANDRIN, G ;
GALTON, DAG ;
GRALNICK, HR ;
SULTAN, C .
BRITISH JOURNAL OF HAEMATOLOGY, 1976, 33 (04) :451-&
[3]   CYTOLOGICAL TYPES OF MITOSES AND CHROMOSOME-ABNORMALITIES IN ACUTE-LEUKEMIA [J].
BERGER, R ;
BERNHEIM, A ;
DANIEL, MT ;
VALENSI, F ;
FLANDRIN, G .
LEUKEMIA RESEARCH, 1983, 7 (02) :221-236
[4]  
BIONDI A, 1991, BLOOD, V77, P1418
[5]   Presenting white blood cell count and kinetics of molecular remission predict prognosis in acute promyelocytic leukemia treated with all-trans retinoic acid:: Result of the randomized MRC trial [J].
Burnett, AK ;
Grimwade, D ;
Solomon, E ;
Wheatley, K ;
Goldstone, AH .
BLOOD, 1999, 93 (12) :4131-4143
[6]  
CASTAIGNE S, 1992, BLOOD, V79, P3110
[7]   SINGLE-STEP METHOD OF RNA ISOLATION BY ACID GUANIDINIUM THIOCYANATE PHENOL CHLOROFORM EXTRACTION [J].
CHOMCZYNSKI, P ;
SACCHI, N .
ANALYTICAL BIOCHEMISTRY, 1987, 162 (01) :156-159
[8]  
Diverio D, 1998, BLOOD, V92, P784
[9]   A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia [J].
Fenaux, P ;
Chastang, C ;
Chevret, S ;
Sanz, M ;
Dombret, H ;
Archimbaud, E ;
Fey, M ;
Rayon, C ;
Huguet, F ;
Sotto, JJ ;
Gardin, C ;
Makhoul, PC ;
Travade, P ;
Solary, E ;
Fegueux, N ;
Bordessoule, D ;
San Miguel, J ;
Link, H ;
Desablens, B ;
Stamatoullas, A ;
Deconinck, E ;
Maloisel, F ;
Castaigne, S ;
Preudhomme, C ;
Degos, L .
BLOOD, 1999, 94 (04) :1192-1200
[10]  
FENAUX P, 1992, BLOOD, V80, P2176